|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics 2020. CA Cancer J Clin. 70:7–30. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386.
2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316.
2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lingen MW, Pinto A, Mendes RA, Franchini
R, Czerninski R, Tilakaratne WM, Partridge M, Peterson DE and Woo
SB: Genetics/epigenetics of oral premalignancy: Current status and
future research. Oral Dis. 17 (Suppl 1):S7–S22. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Nasser W, Flechtenmacher C, Holzinger D,
Hofele C and Bosch XF: Aberrant expression of p53, p16INK4a and
Ki-67 as basic biomarker for malignant progression of oral
leukoplakias. J Oral Pathol Med. 40:629–635. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Solomon I, Voiculescu VM, Caruntu C, Lupu
M, Popa A, Ilie MA, Albulescu R, Caruntu A, Tanase C, Constantin C,
et al: Neuroendocrine factors and head and neck squamous cell
carcinoma: An affair to remember. Dis Markers.
2018(9787831)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Verheijen R, Kuijpers HJ, Schlingemann RO,
Boehmer AL, van Driel R, Brakenhoff GJ and Ramaekers FC: Ki-67
detects a nuclear matrix-associated proliferation-related antigen.
I. Intracellular localization during interphase. J Cell Sci.
92:123–130. 1989.PubMed/NCBI
|
|
9
|
Torres-Rendon A, Roy S, Craig GT and
Speight PM: Expression of Mcm2, geminin and Ki67 in normal oral
mucosa, oral epithelial dysplasias and their corresponding
squamous-cell carcinomas. Br J Cancer. 100:1128–1134.
2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mallick S, Agarwal J, Kannan S, Pawar S,
Kane S and Teni T: PCNA and anti-apoptotic Mcl-1 proteins predict
disease-free survival in oral cancer patients treated with
definitive radiotherapy. Oral Oncol. 46:688–693. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Dionne KR, Warnakulasuriya S, Zain RB and
Cheong SC: Potentially malignant disorders of the oral cavity:
Current practice and future directions in the clinic and
laboratory. Int J Cancer. 136:503–515. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rousseau A, Lim MS, Lin Z and Jordan RC:
Frequent cyclin D1 gene amplification and protein overexpression in
oral epithelial dysplasias. Oral Oncol. 37:268–275. 2001.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Boda D, Docea AO, Calina D, Ilie MA,
Caruntu C, Zurac S, Neagu M, Constantin C, Branisteanu DE,
Voiculescu V, et al: Human papilloma virus: Apprehending the link
with carcinogenesis and unveiling new research avenues (Review).
Int J Oncol. 52:637–655. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Perez-Ordonez B, Beauchemin M and Jordan
RC: Molecular biology of squamous cell carcinoma of the head and
neck. J Clin Pathol. 59:445–453. 2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Öhman J, Mowjood R, Larsson L, Kovacs A,
Magnusson B, Kjeller G, Jontell M and Hasseus B: Presence of
CD3-Positive T-cells in oral premalignant leukoplakia indicates
prevention of cancer transformation. Anticancer Res. 35:311–317.
2015.PubMed/NCBI
|
|
16
|
Chang KW, Lin SC, Kwan PC and Wong YK:
Association of aberrant p53 and p21 (WAF1) immunoreactivity with
the outcome of oral verrucous leukoplakia in Taiwan. J Oral Pathol
Med. 29:56–62. 2000.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Vieira RA, Minicucci EM, Marques ME and
Marques SA: Actinic cheilitis and squamous cell carcinoma of the
lip: Clinical, histopathological and immunogenetic aspects. An Bras
Dermatol. 87:105–114. 2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Calenic B, Greabu M, Caruntu C, Nicolescu
MI, Moraru L, Surdu-Bob CC, Badulescu M, Anghel A, Logofatu C and
Boda D: Oral keratinocyte stem cells behavior on diamond like
carbon films. Rom Biotechnol Lett. 21:11914–11922. 2016.
|
|
19
|
Lu S, Tiekso J, Hietanen S, Syrjänen K,
Havu VK and Syrjänen S: Expression of cell-cycle proteins p53, p21
(WAF-1), PCNA and Ki-67 in Benign, premalignant and malignant skin
lesions with implicated HPV involvement. Acta Derm Venereol.
79:268–273. 1999.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Presland RB and Jurevic RJ: Making sense
of the epithelial barrier: What molecular biology and genetics tell
us about the functions of oral mucosal and epidermal tissues. J
Dent Educ. 66:564–574. 2002.PubMed/NCBI
|
|
21
|
Uchida C: Roles of pRB in the regulation
of nucleosome and chromatin structures. Biomed Res Int.
2016(5959721)2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
de Oliveira GM, Ramalho LM, Gaiao L, Pozza
DH and de Mello RA: Retinoblastoma and p53 protein expression in
pre-malignant oral lesions and oral squamous cell carcinoma.
Molecular Med Rep. 6:163–166. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li F: Role of survivin and its splice
variants in tumorigenesis. Br J Cancer. 92:212–216. 2005.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lupu M, Caruntu A, Caruntu C, Boda D,
Moraru L, Voiculescu V and Bastian A: Non-invasive imaging of
actinic cheilitis and squamous cell carcinoma of the lip. Mol Clin
Oncol. 8:640–646. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lo Muzio L, Pannone G, Leonardi R,
Staibano S, Mignogna MD, de Rosa G, Kudo Y, Takata T and Altieri
DC: Survivin, a potential early predictor of tumor progression in
the oral mucosa. J Dent Res. 82:923–928. 2003.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Xie S, Xu H, Shan X, Liu B, Wang K and Cai
Z: Clinicopathological and prognostic significance of survivin
expression in patients with oral squamous cell carcinoma: Evidence
from a meta-analysis. PLoS One. 10(0116517)2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Thiem DGE, Schneider S, Venkatraman NT,
Kumar VV, Brieger J, Frerich B and Kämmerer PW: Semiquantifiable
angiogenesis parameters in association with the malignant
transformation of oral leukoplakia. J Oral Pathol Med. 46:710–716.
2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Johnstone S and Logan RM: Expression of
vascular endothelial growth factor (VEGF) in normal oral mucosa,
oral dysplasia and oral squamous cell carcinoma. Int J Oral
Maxillofac Surg. 36:263–266. 2007.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Boda D: Cellomics as integrative omics for
cancer. Curr Proteomics. 10:237–245. 2013.
|
|
30
|
Michailidou EZ, Markopoulos AK and
Antoniades DZ: VEGF expression from human dysplastic or malignant
oral epithelium may be related to mast cell density and the
subsequent angiogenetic phenomena. Int J Oral Maxillofac Surg.
41:1467–1473. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Gadbail AR, Chaudhary MS, Sarode SC,
Gawande M, Korde S, Tekade SA, Gondivkar S, Hande A and Maladhari
R: Ki67, CD105, and α-SMA expressions better relate the binary oral
epithelial dysplasia grading system of World Health Organization. J
Oral Pathol Med. 46:921–927. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Stamenkovic I: Extracellular matrix
remodelling: The role of matrix metalloproteinases. J Pathol.
200:448–464. 2003.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kosunen A, Pirinen R, Ropponen K, Pukkila
M, Kellokoski J, Virtaniemi J, Sironen R, Juhola M, Kumpulainen E,
Johansson R, et al: CD44 expression and its relationship with
MMP-9, clinicopathological factors and survival in oral squamous
cell carcinoma. Oral Oncol. 43:51–59. 2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Kivisaari A and Kähäri VM: Squamous cell
carcinoma of the skin: Emerging need for novel biomarkers. World J
Clin Oncol. 4:85–90. 2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Olinici D, Gheucă-Solovăstru L, Stoica L,
Bădescu L, Onofrei P, Botez EA and Cotrutz CE: The molecular mosaic
of the premalignant cutaneous lesions-Review. Rom J Morphol
Embryol. 57:353–359. 2016.PubMed/NCBI
|
|
36
|
Katayama A, Bandoh N, Kishibe K, Takahara
M, Ogino T, Nonaka S and Harabuchi Y: Expressions of matrix
metalloproteinases in early-stage oral squamous cell carcinoma as
predictive indicators for tumor metastases and prognosis. Clin
Cancer Res. 10:634–640. 2004.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Chang PY, Kuo YB, Wu TL, Liao CT, Sun YC,
Yen TC and Chan EC: Association and prognostic value of serum
inflammation markers in patients with leukoplakia and oral cavity
cancer. Clin Chem Lab Med. 51:1291–1300. 2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Saxena G, Koli K, de la Garza J and
Ogbureke KU: Matrix metalloproteinase 20-dentin sialophosphoprotein
interaction in oral cancer. J Dent Res. 94:584–593. 2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Bajracharya D, Shrestha B, Kamath A, Menon
A and Radhakrishnan R: Immunohistochemical correlation of matrix
metalloproteinase-2 and tissue inhibitors of metalloproteinase-2 in
tobacco associated epithelial dysplasia. Dis Markers.
2014(197813)2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
von Zeidler SV, de Souza Botelho T,
Mendonça EF and Batista AC: E-cadherin as a potential biomarker of
malignant transformation in oral leukoplakia: A retrospective
cohort study. BMC Cancer. 14(972)2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Williams HK, Sanders DS, Jankowski JA,
Landini G and Brown AM: Expression of cadherins and catenins in
oral epithelial dysplasia and squamous cell carcinoma. J Oral
Pathol Med. 27:308–317. 1998.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Papadimitrakopoulou VA, William WN Jr,
Dannenberg AJ, Lippman SM, Lee JJ, Ondrey FG, Peterson DE, Feng L,
Atwell A, El-Naggar AK, et al: Pilot randomized phase II study of
celecoxib in oral premalignant lesions. Clin Cancer Res.
14:2095–2101. 2008.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Saba NF, Haigentz M Jr, Vermorken JB,
Strojan P, Bossi P, Rinaldo A, Takes RP and Ferlito A: Prevention
of head and neck squamous cell carcinoma: Removing the ‘chemo’ from
‘chemoprevention’. Oral Oncol. 51:112–118. 2015.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Jyothi Meka N, Ugrappa S, Velpula N, Kumar
S, Naik Maloth K, Kodangal S, Ch L and Goyal S: Quantitative
immunoexpression of EGFR in oral potentially malignant disorders:
Oral leukoplakia and oral submucous fibrosis. J Dent Res Dent Clin
Dent Prospects. 9:166–174. 2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Ribeiro DC, Gleber-Netto FO, Sousa SF,
Bernardes VD, Guimaraes-Abreu MH and Aguiar MC: Immunohistochemical
expression of EGFR in oral leukoplakia: Association with
clinicopathological features and cellular proliferation. Med Oral
Patol Oral Cir Bucal. 17:e739–e744. 2012.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Taoudi Benchekroun M, Saintigny P, Thomas
SM, El-Naggar AK, Papadimitrakopoulou V, Ren H, Lang W, Fan YH,
Huang J, Feng L, et al: Epidermal growth factor receptor expression
and gene copy number in the risk of oral cancer. Cancer Prev Res
(Phila). 3:800–809. 2010.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Poh CF, Zhu Y, Chen E, Berean KW, Wu L,
Zhang L and Rosin MP: Unique FISH patterns associated with cancer
progression of oral dysplasia. J Dental Res. 91:52–57.
2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Saba NF, Hurwitz SJ, Kono SA, Yang CS,
Zhao Y, Chen Z, Sica G, Müller S, Moreno-Williams R, Lewis M, et
al: Chemoprevention of head and neck cancer with celecoxib and
erlotinib: Results of a phase ib and pharmacokinetic study. Cancer
Prev Res (Phila). 7:283–291. 2014.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Amornphimoltham P, Patel V, Sodhi A,
Nikitakis NG, Sauk JJ, Sausville EA, Molinolo AA and Gutkind JS:
Mammalian target of rapamycin, a molecular target in squamous cell
carcinomas of the head and neck. Cancer Res. 65:9953–9961.
2005.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Martins F, de Sousa SC, Dos Santos E, Woo
SB and Gallottini M: PI3KAKT-mTOR pathway proteins are differently
expressed in oral carcinogenesis. J Oral Pathol Med. 45:746–752.
2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Navarro P, Gómez M, Pizarro A, Gamallo C,
Quintanilla M and Cano A: A role for the E-Cadherin cell-cell
adhesion molecule during tumor progression of mouse epidermal
carcinogenesis. J Cell Biol. 115:517–533. 1991.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Brennan D, Hu Y, Joubeh S, Choi YW,
Whitaker-Menezes D, O'Brien T, Uitto J, Rodeck U and Mahoney MG:
Suprabasal Dsg2 expression in transgenic mouse skin confers a
hyperproliferative and apoptosis-resistant phenotype to
keratinocytes. J Cell Sci. 120 (Pt 5):758–771. 2007.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Alt-Holland A, Zhang W, Margulis A and
Garlick JA: Microenvironmental control of premalignant disease: The
role of intercellular adhesion in the progression of squamous cell
carcinoma. Semin Cancer Biol. 15:84–96. 2005.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Chidgey M and Dawson C: Desmosomes: A role
in cancer? Br J Cancer. 96:1783–1787. 2007.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Vilen ST, Salo T, Sorsa T and Nyberg P:
Fluctuating roles of matrix metalloproteinase 9 in oral squamous
cell carcinoma. ScientificWorldJournal. 2013(920595)2013.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Bagheri M, Eghtedari M, Bagheri M,
Geramizadeh B and Talebnejad M: Expression of maspin and ezrin
proteins in periocular basal cell carcinoma. Dermatol Res Pract.
2014(596564)2014.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Gamei MM, el Naby NMA, El-Ashmawy AA and
Shareef MM: Prognostic value of ezrin expression in common
epithelial tumors: An immunohistochemical study. J Microsc
Ultrastructure. 2:67–76. 2014.
|
|
58
|
Kaur J, Sawhney M, DattaGupta S, Shukla
NK, Srivastava A, Walfish PG and Ralhan R: Clinical significance of
altered expression of β-catenin and E-cadherin in oral dysplasia
and cancer: Potential link with ALCAM expression. PLoS One.
8(e67361)2013.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Suciu M, Morariu SH, Ormenişan A, Grigoraş
RI, Bostan RH, Mocanu S, Vartolomei MD and Cotoi OS: Oral squamous
cell carcinoma of the maxilla, a second malignancy after a right
ethmoido-maxillary chondrosarcoma. Rom J Morphol Embryol. 55 (Suppl
3):S1247–S1251. 2014.PubMed/NCBI
|
